 |
 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 February 2001 | Volume 134 Issue 4 | Pages 298-314
Antimicrobial resistance has emerged as an important determinant of outcome for patients in the intensive care unit (ICU). This is largely due to the administration of inadequate antimicrobial treatment, which is most often related to bacterial antibiotic resistance. In addition, the escalating problem of antimicrobial resistance has substantially increased overall health care costs. This increase is a result of prolonged hospitalizations and convalescence associated with antibiotic treatment failures, the need to develop new antimicrobial agents, and the implementation of broader infection control and public health interventions aimed at curbing the spread of antibiotic-resistant pathogens. Intensive care units are unique because they house seriously ill patients in confined environments where antibiotic use is extremely common. They have been focal points for the emergence and spread of antibiotic-resistant pathogens. Effective strategies for the prevention of antimicrobial resistance in ICUs have focused on limiting the unnecessary use of antibiotics and increasing compliance with infection control practices. Clinicians caring for critically ill patients should consider antimicrobial resistance as part of their routine treatment plans. Careful, focused attention to this problem at the local ICU level, using a multidisciplinary approach, will have the greatest likelihood of limiting the development and dissemination of antibiotic-resistant infections.
Author and Article Information
From Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, Missouri.
Acknowledgments:The authors thank Kim Tinsley for her assistance in preparing this manuscript.
Grant Support:In part by a grant from the Centers for Disease Control and Prevention (UR8/CCU715087).
Requests for Single Reprints:Marin H. Kollef, MD, Campus Box 8052, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110; e-mail, kollefm{at}msnotes.wustl.edu.
Current Author Addresses:Dr. Kollef: Campus Box 8052, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110.
Dr. Fraser: Campus Box 8051, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110. REVIEW
Antibiotic Resistance in the Intensive Care Unit
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  S. Habibi, N. Wig, S. Agarwal, S. K Sharma, R. Lodha, R. M Pandey, and A. Kapil Epidemiology of nosocomial infections in medicine intensive care unit at a tertiary care hospital in northern India Trop Doct, October 1, 2008; 38(4): 233 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Florescu, M. Beuran, R. Dimov, A. Razbadauskas, M. Bochan, G. Fichev, G. Dukart, T. Babinchak, C. A. Cooper, E. J. Ellis-Grosse, et al. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study J. Antimicrob. Chemother., September 1, 2008; 62(suppl_1): i17 - i28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Masterton, A. Galloway, G. French, M. Street, J. Armstrong, E. Brown, J. Cleverley, P. Dilworth, C. Fry, A. D. Gascoigne, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy J. Antimicrob. Chemother., July 1, 2008; 62(1): 5 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bootsma, M. Bonten, S Nijssen, A. Fluit, and O Diekmann An Algorithm to Estimate the Importance of Bacterial Acquisition Routes in Hospital Settings Am. J. Epidemiol., October 1, 2007; 166(7): 841 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rello Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia Eur. Respir. Rev., August 1, 2007; 16(103): 33 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Merz, D. K. Warren, M. H. Kollef, S. K. Fridkin, and V. J. Fraser The Impact of an Antibiotic Cycling Program on Empirical Therapy for Gram-Negative Infections Chest, December 1, 2006; 130(6): 1672 - 1678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Kollef Time to get serious about infection prevention in the ICU. Chest, November 1, 2006; 130(5): 1293 - 1296. [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Scheetz, K. M. Hurt, G. A. Noskin, and C. M. Oliphant Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens. Am. J. Health Syst. Pharm., July 15, 2006; 63(14): 1346 - 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. H. Edwards, R. M. Engelman, P. Houck, D. M. Shahian, and C. R. Bridges The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration Ann. Thorac. Surg., January 1, 2006; 81(1): 397 - 404. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Morrell, V. J. Fraser, and M. H. Kollef Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3640 - 3645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sierra, E. Benitez, C. Leon, and J. Rello Prevention and Diagnosis of Ventilator-Associated Pneumonia: A Survey on Current Practices in Southern Spanish ICUs Chest, September 1, 2005; 128(3): 1667 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Brun-Buisson, M. Fartoukh, E. Lechapt, S. Honore, J.-R. Zahar, C. Cerf, and B. Maitre Contribution of Blinded, Protected Quantitative Specimens to the Diagnostic and Therapeutic Management of Ventilator-Associated Pneumonia Chest, August 1, 2005; 128(2): 533 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Micek, A. E. Lloyd, D. J. Ritchie, R. M. Reichley, V. J. Fraser, and M. H. Kollef Pseudomonas aeruginosa Bloodstream Infection: Importance of Appropriate Initial Antimicrobial Treatment Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1306 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kadowaki, Y. Demura, S. Mizuno, D. Uesaka, S. Ameshima, I. Miyamori, and T. Ishizaki Reappraisal of Clindamycin IV Monotherapy for Treatment of Mild-to-Moderate Aspiration Pneumonia in Elderly Patients Chest, April 1, 2005; 127(4): 1276 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Safdar, J. P. Fine, and D. G. Maki Meta-Analysis: Methods for Diagnosing Intravascular Device-Related Bloodstream Infection Ann Intern Med, March 15, 2005; 142(6): 451 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Wilson, L. J. Oyen, N. N. Ou, M. M. McMahon, R. L. Thompson, J. M. Manahan, K. K. Graner, J. K. Lovely, and L. L. Estes Hospital rules-based system: The next generation of medical informatics for patient safety Am. J. Health Syst. Pharm., March 1, 2005; 62(5): 499 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. van Loon, M. R. Vriens, A. C. Fluit, A. Troelstra, C. van der Werken, J. Verhoef, and M. J. M. Bonten Antibiotic Rotation and Development of Gram-Negative Antibiotic Resistance Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 480 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Nopmaneejumruslers and C. K.N. Chan Is There a Role for Routine Surveillance Endotracheal Aspirate Cultures in the Treatment of BAL-Confirmed Ventilator-Associated Pneumonia? Chest, February 1, 2005; 127(2): 425 - 427. [Full Text] [PDF]
|
|
|
|
|
|
S. Ramanathan-Girish, J. McColm, J. M. Clements, P. Taupin, S. Barrowcliffe, J. Hevizi, S. Safrin, C. Moore, G. Patou, H. Moser, et al. Pharmacokinetics in Animals and Humans of a First-in-Class Peptide Deformylase Inhibitor Antimicrob. Agents Chemother., December 1, 2004; 48(12): 4835 - 4842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Bergstrom, M. Lo, and M. Lipsitch From The Cover: Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals PNAS, September 7, 2004; 101(36): 13285 - 13290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Osmon, S. Ward, V. J. Fraser, and M. H. Kollef Hospital Mortality for Patients With Bacteremia Due to Staphylococcus aureus or Pseudomonas aeruginosa Chest, February 1, 2004; 125(2): 607 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ioanas, M. Cavalcanti, M. Ferrer, M. Valencia, C. Agusti, J. Puig de la Bellacasa, and A. Torres Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines Eur. Respir. J., December 1, 2003; 22(6): 876 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chastre, M. Wolff, J.-Y. Fagon, S. Chevret, F. Thomas, D. Wermert, E. Clementi, J. Gonzalez, D. Jusserand, P. Asfar, et al. Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults: A Randomized Trial JAMA, November 19, 2003; 290(19): 2588 - 2598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gross, R. Burli, P. Jones, M. Garcia, B. Batiste, J. Kaizerman, H. Moser, V. Jiang, U. Hoch, J.-X. Duan, et al. Pharmacology of Novel Heteroaromatic Polycycle Antibacterials Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3448 - 3457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Chamot, E. Boffi El Amari, P. Rohner, and C. Van Delden Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia Antimicrob. Agents Chemother., September 1, 2003; 47(9): 2756 - 2764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Osmon, D. Warren, S. M. Seiler, W. Shannon, V. J. Fraser, and M. H. Kollef The Influence of Infection on Hospital Mortality for Patients Requiring > 48 h of Intensive Care Chest, September 1, 2003; 124(3): 1021 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J-Y. Fagon and J. Chastre Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients Eur. Respir. J., August 1, 2003; 22(42_suppl): 77s - 83s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Rubenfeld Is SARS Just ARDS? JAMA, July 16, 2003; 290(3): 397 - 399. [Full Text] [PDF]
|
|
|
|
|
|
O. Leroy, S. Jaffre, T. d'Escrivan, P. Devos, H. Georges, S. Alfandari, and G. Beaucaire Hospital-Acquired Pneumonia: Risk Factors for Antimicrobial-Resistant Causative Pathogens in Critically Ill Patients Chest, June 1, 2003; 123(6): 2034 - 2042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Brun-Buisson Antibiotic Therapy of Ventilator-Associated Pneumonia: In Search of the Magic Bullet Chest, March 1, 2003; 123(3): 670 - 673. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Toltzis, M. J. Dul, C. Hoyen, A. Salvator, M. Walsh, L. Zetts, and H. Toltzis The Effect of Antibiotic Rotation on Colonization With Antibiotic-Resistant Bacilli in a Neonatal Intensive Care Unit Pediatrics, October 1, 2002; 110(4): 707 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Leroy, P. Giradie, Y. Yazdanpanah, H. Georges, S. Alfandari, V. Sanders, P. Devos, and G. Beaucaire Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Eur. Respir. J., August 1, 2002; 20(2): 432 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Safdar and D. G. Maki The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida Ann Intern Med, June 4, 2002; 136(11): 834 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chastre and J.-Y. Fagon Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 867 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. H. Levy Computerized Anti-infection Management in the PICU AAP Grand Rounds, March 1, 2002; 7(3): 34 - 35. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Balk Is a Silver Coating a Silver Lining? Chest, March 1, 2002; 121(3): 682 - 683. [Full Text] [PDF]
|
|
|
|
|
|
J. R. Johnson Prevention of Antibiotic Resistance in Hospitals Ann Intern Med, January 15, 2002; 136(2): 173 - 173. [Full Text] [PDF]
|
|
|
|
|
|
N. Singh and V. L. Yu Prevention of Antibiotic Resistance in Hospitals Ann Intern Med, January 15, 2002; 136(2): 173 - 173. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Carrier, R. Marchand, P. Auger, Y. Hebert, M. Pellerin, L. P. Perrault, R. Cartier, D. Bouchard, N. Poirier, and P. Page Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 40 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Osmon Antimicrobial Resistance: Guidelines for the Practicing Orthopaedic Surgeon J. Bone Joint Surg. Am., December 1, 2001; 83(12): 1891 - 1901. [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Palumbi Humans as the World's Greatest Evolutionary Force Science, September 7, 2001; 293(5536): 1786 - 1790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Marik and J. Varon Ventilator-Associated Pneumonia : Science and Hocus-Pocus Chest, September 1, 2001; 120(3): 702 - 704. [Full Text] [PDF]
|
|
Article
